OS Therapies, Inc. (OSTX)
1.77
+0.03
(+1.72%)
USD |
NYAM |
Sep 22, 16:00
1.79
+0.02
(+1.13%)
After-Hours: 20:00
OS Therapies Price : 1.77 for Sept. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | 1.76 | 1.84 | 1.74 | 1.77 | 600391.0 |
| Sep 21, 2026 | 1.81 | 1.815 | 1.74 | 1.74 | 637059.0 |
| Sep 18, 2026 | 1.81 | 1.83 | 1.76 | 1.77 | 908579.0 |
| Sep 17, 2026 | 1.80 | 2.00 | 1.80 | 1.83 | 2.231M |
| Sep 16, 2026 | 1.79 | 1.82 | 1.74 | 1.75 | 421327.0 |
| Sep 15, 2026 | 1.78 | 1.81 | 1.71 | 1.78 | 1.054M |
| Sep 14, 2026 | 1.65 | 1.79 | 1.62 | 1.70 | 993722.0 |
| Sep 11, 2026 | 1.81 | 1.840 | 1.66 | 1.68 | 825872.0 |
| Sep 10, 2026 | 1.87 | 1.92 | 1.81 | 1.82 | 547914.0 |
| Sep 09, 2026 | 1.83 | 1.92 | 1.80 | 1.86 | 393180.0 |
| Sep 08, 2026 | 1.96 | 2.015 | 1.750 | 1.83 | 1.768M |
| Sep 04, 2026 | 1.84 | 1.96 | 1.84 | 1.88 | 982579.0 |
| Sep 03, 2026 | 1.72 | 1.84 | 1.72 | 1.82 | 894277.0 |
| Sep 02, 2026 | 1.68 | 1.72 | 1.61 | 1.71 | 530467.0 |
| Sep 01, 2026 | 1.68 | 1.705 | 1.63 | 1.66 | 400615.0 |
| Aug 31, 2026 | 1.62 | 1.690 | 1.62 | 1.69 | 234957.0 |
| Aug 28, 2026 | 1.69 | 1.69 | 1.60 | 1.64 | 294985.0 |
| Aug 27, 2026 | 1.65 | 1.72 | 1.641 | 1.68 | 518150.0 |
| Aug 26, 2026 | 1.65 | 1.65 | 1.60 | 1.65 | 351463.0 |
| Aug 25, 2026 | 1.53 | 1.65 | 1.53 | 1.65 | 351234.0 |
| Aug 24, 2026 | 1.50 | 1.55 | 1.460 | 1.55 | 438883.0 |
| Aug 21, 2026 | 1.56 | 1.635 | 1.56 | 1.59 | 386419.0 |
| Aug 20, 2026 | 1.50 | 1.58 | 1.45 | 1.58 | 369641.0 |
| Aug 19, 2026 | 1.46 | 1.47 | 1.40 | 1.46 | 283642.0 |
| Aug 18, 2026 | 1.48 | 1.51 | 1.43 | 1.44 | 231505.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.41 |
| Alnylam Pharmaceuticals, Inc. | 251.65 |
| Anika Therapeutics, Inc. | 20.89 |
| Savara, Inc. | 5.30 |
| Vericel Corp. | 40.22 |
Price Related Metrics
| PEG Ratio | -0.0507 |
| Earnings Yield | -58.95% |
| Market Cap | 80.15M |
| PEGY Ratio | -0.0507 |